Browse Category

NASDAQ:UAA News 31 December 2025 - 9 January 2026

Lululemon stock sinks nearly 5% as Supreme Court tariff ruling slips, keeping retailers on edge

Lululemon stock sinks nearly 5% as Supreme Court tariff ruling slips, keeping retailers on edge

lululemon athletica shares fell 4.9% to $201.88 Friday after the U.S. Supreme Court delayed a key tariffs ruling. The company warned higher tariffs and loss of the “de minimis” exemption could cut 2025 gross profit by $240 million. Investors also weighed an upcoming CEO transition and a proxy fight from founder Chip Wilson. The court could rule next week.
Under Armour stock steadies near $5 as Fairfax boosts stake to 16.1%

Under Armour stock steadies near $5 as Fairfax boosts stake to 16.1%

Under Armour shares hovered near $5 premarket Wednesday after Fairfax Financial disclosed it bought about 15.7 million shares across two classes in late December. Fairfax and affiliates now own over 30 million Class A shares, or 16.1% of that class. The purchases totaled roughly $71 million at prices between $4.36 and $4.73. Investors await Under Armour’s next quarterly update in early 2026.
31 December 2025

Stock Market Today

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

7 February 2026
Disney shares closed up 3.6% at $108.70 Friday, recovering from earlier losses as U.S. stocks rallied and the Dow topped 50,000. Investors are watching Super Bowl streaming economics and Disney’s CEO transition, with Josh D’Amaro set to take over at the March 18 meeting. Disney reported quarterly revenue of $25.98 billion and adjusted EPS of $1.63, while segment operating income fell 9% to $4.6 billion.
Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

7 February 2026
Novo Nordisk Class B shares closed up 5.3% at 295.50 Danish crowns in Copenhagen after Hims & Hers said it would stop offering a compounded pill version of Wegovy following U.S. regulatory warnings. The move came after Novo called the Hims product “illegal mass compounding” and threatened legal action. Shares had fallen nearly 8% Thursday after Hims launched the pill. Trading resumes Monday.
Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

7 February 2026
Linde plc shares fell 2.5% to $448.24 Friday after reporting Q4 sales up 6% to $8.76 billion and adjusted EPS of $4.20. The company guided 2026 adjusted EPS to $17.40–$17.90, below analyst consensus. JPMorgan downgraded the stock, while Morgan Stanley and UBS raised price targets. Linde repurchased $1.4 billion in shares in Q4 and returned $7.4 billion to shareholders in 2025.
Go toTop